Xu, Hui

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

Noda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 657

Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin

Esaki, H., Brunner, P. M., Renert-Yuval, Y., Czarnowicki, T., Huynh, T., Tran, G., Lyon, S., Rodriguez, G., Immaneni, S., Johnson, D. B., et al. (2016) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 428

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response

Dhingra, N., Shemer, A., Correa da Rosa, J., Rozenblit, M., Fuentes-Duculan, J., Gittler, J. K., Finney, R., Czarnowicki, T., Zheng, X., Xu, H., et al. (2014) · Journal of Allergy and Clinical Immunology

Contact Dermatitis and AllergiesDermatology and Skin Diseases

Cited by 305

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Guttman-Yassky, E., Pavel, A. B., Zhou, L., Estrada, Y. D., Zhang, N., Xu, H., Peng, X., Wen, H.-C., Govas, P., Gudi, G., et al. (2019) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 220

Petrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer

Czarnowicki, T., Malajian, D., Khattri, S., Correa da Rosa, J., Dutt, R., Finney, R., Dhingra, N., Xiangyu, P., Xu, H., Estrada, Y. D., et al. (2016) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 161

Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis

Zhou, L., Leonard, A., Pavel, A. B., Malik, K., Raja, A., Glickman, J., Estrada, Y. D., Peng, X., del Duca, E., Sanz-Cabanillas, J., et al. (2019) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 146

A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis

Simpson, E. L., Imafuku, S., Poulin, Y., Ungar, B., Zhou, L., Malik, K., Wen, H.-C., Xu, H., Estrada, Y. D., Peng, X., et al. (2019) · Journal of Investigative Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 120

Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis

Ungar, B., Pavel, A. B., Li, R., Kimmel, G., Nia, J., Hashim, P., Kim, H. J., Chima, M., Vekaria, A. S., Estrada, Y., et al. (2021) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 119

Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features

Chan, T. C., Sanyal, R. D., Pavel, A. B., Glickman, J., Zheng, X., Xu, H., Cho, Y.-T., Tsai, T.-F., Wen, H.-C., Peng, X., et al. (2018) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 114